Showing results (41-50 of 212) with videos related to
Sort By:
Pageof 22
Journal of General Internal Medicine|February 8, 2005
Patient-physician web messaging. The impact on message volume and satisfactionEric M Liederman, Jerry C Lee, Victor H Baquero, et al.Journal of Healthcare Information Management : JHIM|May 5, 2005
The impact of patient-physician Web messaging on provider productivityEric M Liederman, Jerry C Lee, Victor H Baquero, et al.The Journal of Infectious Diseases|July 12, 2011
Bacteroides fragilis-stimulated interleukin-10 contains expanding diseaseRonit Cohen-Poradosu, Rachel M McLoughlin, Jerry C Lee, et al.Age and Ageing|January 3, 2026
Supporting safe walking and managing missing incidents in dementia: a qualitative narrative synthesis of current evidenceHoi Tat Kwok, Annika Dhawan, Valerie Lye, et al.Journal of Virology|October 9, 2002
Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligationLawrence Fong, Manuela Mengozzi, Nancy W Abbey, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 29, 2020
Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?Daniel Vargas P de Almeida, Lawrence Fong, Matthew B Rettig, et al.Science Translational Medicine|May 30, 2014
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patientsEdward Cha, Mark Klinger, Yafei Hou, et al.Age and Ageing|May 12, 2026
Characteristics of missing incidents and risk factors for harm for older people with and without dementia in the UKVasiliki Orgeta, Garrett Kidd, Jean Stafford, et al.Journal for Immunotherapy of Cancer|February 9, 2022
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapyRyan C Augustin, Robert D Leone, Aung Naing, et al.Cancer|June 1, 2006
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapyBrian I Rini, Vivian Weinberg, Lawrence Fong, et al.Pageof 22